Skip to main content
logo
BioNTech SE (ETR:22UA)
Germany flag Germany · Delayed Price · Currency is EUR
91.40
-3.40 (-3.59%)
At close: Apr 23, 2026

BioNTech SE Revenue

In the year 2025, BioNTech SE had annual revenue of 2.87B EUR with 4.32% growth. BioNTech SE had revenue of 907.40M in the quarter ending December 31, 2025, a decrease of -23.75%.

Revenue
2.87B
Revenue Growth
+4.32%
P/S Ratio
7.94
Revenue / Employee
367.61K
Employees
7,807
Market Cap
22.79B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.87B118.80M4.32%
Dec 31, 20242.75B-1.07B-27.96%
Dec 31, 20233.82B-13.49B-77.94%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bayer Aktiengesellschaft45.58B
Siemens Healthineers AG23.30B
Fresenius SE & Co. KGaA22.87B
Merck KGaA21.10B
Fresenius Medical Care AG19.63B
Sartorius Aktiengesellschaft3.54B
Fielmann Group AG2.42B
Carl Zeiss Meditec AG2.20B
Revenue Rankings

BioNTech SE News

More News